Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Cervera

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
European Journal of Haematology|March 31, 2011
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopeniaCarlos Cervera, Francesc Fernández-Avilés, Oscar de la Calle-Martin, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Plos One|May 12, 2015
Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentrationCristina García de la Mària, Carlos Cervera, Juan M Pericàs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 8, 2011
Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort studyAsunción Moreno, Carlos Cervera, Jesús Fortún, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2014
Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipientsFaouzi Saliba, Andreas Pascher, Olivier Cointault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipientsOscar Len, Joan Gavaldà, José María Aguado, et al.
Frontiers in Immunology|August 26, 2022
Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort StudyMarta Bodro, Carlos Cervera, Laura Linares, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2009
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control studyNúria Fernàndez-Sabé, Carlos Cervera, Francisco López-Medrano, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided EndocarditisJuan M Pericàs, Carlos Cervera, Cristina Garcia-de-la-Mària, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 9, 2012
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort studyOscar Len, Dolores Rodríguez-Pardo, Joan Gavaldà, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
European Journal of Haematology|March 31, 2011
Non-myeloablative hematopoietic stem cell transplantation in the treatment of severe idiopathic CD4+ lymphocytopeniaCarlos Cervera, Francesc Fernández-Avilés, Oscar de la Calle-Martin, et al.
Journal of Global Antimicrobial Resistance|May 13, 2021
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registryGeorge G Zhanel, Rita Dhami, Melanie Baxter, et al.
Plos One|May 12, 2015
Epidemiology and prognosis of coagulase-negative staphylococcal endocarditis: impact of vancomycin minimum inhibitory concentrationCristina García de la Mària, Carlos Cervera, Juan M Pericàs, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 8, 2011
Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort studyAsunción Moreno, Carlos Cervera, Jesús Fortún, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2014
Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipientsFaouzi Saliba, Andreas Pascher, Olivier Cointault, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipientsOscar Len, Joan Gavaldà, José María Aguado, et al.
Frontiers in Immunology|August 26, 2022
Polygenic Innate Immunity Score to Predict the Risk of Cytomegalovirus Infection in CMV D+/R- Transplant Recipients. A Prospective Multicenter Cohort StudyMarta Bodro, Carlos Cervera, Laura Linares, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2009
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control studyNúria Fernàndez-Sabé, Carlos Cervera, Francisco López-Medrano, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Relationship between Vancomycin MIC and Virulence Gene Expression in Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus Strains Isolated from Left-Sided EndocarditisJuan M Pericàs, Carlos Cervera, Cristina Garcia-de-la-Mària, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|October 9, 2012
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: a prospective and multicentre cohort studyOscar Len, Dolores Rodríguez-Pardo, Joan Gavaldà, et al.
Pageof 13